NEW YORK (GenomeWeb) – Ambry Genetics announced today that it will partner with Invicro to provide customized genomics and imaging services for the biotechnology and pharmaceutical industry, with a specialized focus on oncology and neurodegenerative diseases.

The partnership will combine Invicro's imaging services and software with Ambry's genomics services to expedite new drug discovery and development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.